These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 8752137)
21. GR138676, a novel peptidic tachykinin antagonist which is potent at NK3 receptors. Stables JM; Beresford IJ; Arkinstall S; Ireland SJ; Walsh DM; Seale PW; Ward P; Hagan RM Neuropeptides; 1994 Dec; 27(6):333-41. PubMed ID: 7534879 [TBL] [Abstract][Full Text] [Related]
22. In vitro and in vivo characterization of NK3 receptors in the rabbit eye by use of selective non-peptide NK3 receptor antagonists. Medhurst AD; Hay DW; Parsons AA; Martin LD; Griswold DE Br J Pharmacol; 1997 Oct; 122(3):469-76. PubMed ID: 9351503 [TBL] [Abstract][Full Text] [Related]
23. A new selective bioassay for tachykinin NK3 receptors based on inositol monophosphate accumulation in the guinea pig ileum. Petitet F; Saffroy M; Torrens Y; Glowinski J; Beaujouan JC Eur J Pharmacol; 1993 Oct; 247(2):185-91. PubMed ID: 7506659 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of Ca(2+)-sensitive K+ currents in NG 108-15 cells by substance P and related tachykinins. Phenna S; Carpenter E; Peers C; Maudsley S; Gent JP Br J Pharmacol; 1996 Sep; 119(2):315-20. PubMed ID: 8886415 [TBL] [Abstract][Full Text] [Related]
25. The non-peptide tachykinin NK2 receptor antagonist SR 48968 interacts with human, but not rat, cloned tachykinin NK3 receptors. Chung FZ; Wu LH; Vartanian MA; Watling KJ; Guard S; Woodruff GN; Oxender DL Biochem Biophys Res Commun; 1994 Feb; 198(3):967-72. PubMed ID: 8117304 [TBL] [Abstract][Full Text] [Related]
26. Tachykinin receptor expression and function in human esophageal smooth muscle. Kovac JR; Chrones T; Preiksaitis HG; Sims SM J Pharmacol Exp Ther; 2006 Aug; 318(2):513-20. PubMed ID: 16714401 [TBL] [Abstract][Full Text] [Related]
27. Neurokinin receptors (NK1, NK2) in the mouse: a pharmacological study. Nsa Allogho S; Nguyen-Le XK; Gobeil F; Pheng LH; Regoli D Can J Physiol Pharmacol; 1997 Jun; 75(6):552-7. PubMed ID: 9276127 [TBL] [Abstract][Full Text] [Related]
28. Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonists. Picard P; Regoli D; Couture R Br J Pharmacol; 1994 May; 112(1):240-9. PubMed ID: 7518304 [TBL] [Abstract][Full Text] [Related]
29. Tachykinins mediate contraction of the human lower esophageal sphincter in vitro via activation of NK2 receptors. Huber O; Bertrand C; Bunnett NW; Pellegrini CA; Nadel JA; Nakazato P; Debas HT; Geppetti P Eur J Pharmacol; 1993 Aug; 239(1-3):103-9. PubMed ID: 8223885 [TBL] [Abstract][Full Text] [Related]
30. Characterization of antisera specific to NK1, NK2, and NK3 neurokinin receptors and their utilization to localize receptors in the rat gastrointestinal tract. Grady EF; Baluk P; Böhm S; Gamp PD; Wong H; Payan DG; Ansel J; Portbury AL; Furness JB; McDonald DM; Bunnett NW J Neurosci; 1996 Nov; 16(21):6975-86. PubMed ID: 8824334 [TBL] [Abstract][Full Text] [Related]
31. Activin A and all-trans-retinoic acid cooperatively enhanced the functional activity of L-type Ca2+ channels in the neuroblastoma C1300 cell line. Fukuhara S; Mukai H; Munekata E Biochem Biophys Res Commun; 1997 Dec; 241(2):363-8. PubMed ID: 9425277 [TBL] [Abstract][Full Text] [Related]
32. Pharmacological characterization of tachykinin-induced intracellular calcium rise in a human NK2 receptor transfected cell line. Subramanian N; Ruesch C; Bertrand C Biochem Biophys Res Commun; 1994 May; 200(3):1512-20. PubMed ID: 8185607 [TBL] [Abstract][Full Text] [Related]
33. Distinct presynaptic control of dopamine release in striosomal- and matrix-enriched areas of the rat striatum by selective agonists of NK1, NK2, and NK3 tachykinin receptors. Tremblay L; Kemel ML; Desban M; Gauchy C; Glowinski J Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11214-8. PubMed ID: 1280822 [TBL] [Abstract][Full Text] [Related]
34. Demonstration of a 'septide-sensitive' inflammatory response in rat skin. Ahluwalia A; Giuliani S; Maggi CA Br J Pharmacol; 1995 Oct; 116(4):2170-4. PubMed ID: 8564245 [TBL] [Abstract][Full Text] [Related]
35. Potency and selectivity of the tachykinin NK3 receptor antagonist SR 142801. Beaujouan JC; Saffroy M; Torrens Y; Glowinski J Eur J Pharmacol; 1997 Jan; 319(2-3):307-16. PubMed ID: 9042606 [TBL] [Abstract][Full Text] [Related]
36. Canine intrinsic cardiac neurons involved in cardiac regulation possess NK1, NK2, and NK3 receptors. Thompson GW; Hoover DB; Ardell JL; Armour JA Am J Physiol; 1998 Nov; 275(5):R1683-9. PubMed ID: 9791091 [TBL] [Abstract][Full Text] [Related]
38. Neurokinin A-induced vasoconstriction and muscular contraction in the rat isolated stomach: mediation by distinct and unusual neurokinin2 receptors. Lippe I; Wachter CH; Holzer P J Pharmacol Exp Ther; 1997 Jun; 281(3):1294-302. PubMed ID: 9190865 [TBL] [Abstract][Full Text] [Related]
39. A pharmacological study of NK1 and NK2 tachykinin receptor characteristics in the rat isolated urinary bladder. Hall JM; Flowers JM; Morton IK Br J Pharmacol; 1992 Nov; 107(3):777-84. PubMed ID: 1282072 [TBL] [Abstract][Full Text] [Related]
40. Evidence that tachykinin NK1 and NK2 receptors mediate non-adrenergic non-cholinergic excitation and contraction in the circular muscle of guinea-pig duodenum. Zagorodnyuk V; Santicioli P; Maggi CA; Giachetti A Br J Pharmacol; 1995 May; 115(2):237-46. PubMed ID: 7545517 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]